Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study
- PMID: 34697866
- DOI: 10.1111/imj.15598
Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study
Abstract
Background: The Surviving Sepsis Campaign Guidelines recommend stress ulcer prophylaxis (SUP) for patients with sepsis who have gastrointestinal (GI) bleeding risks; however, the effect of SUP has not been specially studied in these patients.
Aims: To determine the effects of SUP versus no prophylaxis on patient-important outcomes in critically ill adult patients with sepsis who have risk factors for GI bleeding.
Methods: This retrospective cohort study utilised data from the Medical Information Mart for Intensive Care III database. We compared those who received SUP with proton-pump inhibitors or histamine-2 receptor antagonists for ≥3 days with those who received no prophylaxis. Propensity score matching (PSM) was conducted to make comparisons between groups with similar distributions of study variables. The primary outcome was inhospital mortality.
Results: A total of 7744 patients were included in the analysis, with 1088 (14.0%) in the non-SUP group and 6656 (86.0%) in the SUP group. A 1:1 PSM created 866 patients in each cohort. No significant differences were noted between the two groups with regard to inhospital mortality (22.3% vs 20.4%; P = 0.379), GI bleeding (4.7% vs 6.4%; P = 0.172), pneumonia (38.9% vs 36.6%; P = 0.346), Clostridium difficile infection (CDI) (6.4% vs 8.9%; P = 0.0.057) or intensive care unit (ICU) length of stay (LOS) (4.2 days vs 4.6 days; P = 0.394).
Conclusions: Among critically ill, septic, adult patients at risk for GI bleeding, SUP showed no effect on hospital mortality, the rate of GI bleeding, pneumonia, CDI and ICU LOS.
Keywords: critically ill; gastrointestinal bleeding; propensity score matching; sepsis; stress ulcer prophylaxis.
© 2021 Royal Australasian College of Physicians.
Similar articles
-
[Efficacy and safety of stress ulcer prophylaxis in septic patients: a retrospective cohort study based on large database].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):641-647. doi: 10.3760/cma.j.cn121430-20210402-00504. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296679 Chinese.
-
Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.J Intensive Care Med. 2023 Oct;38(10):917-921. doi: 10.1177/08850666231171327. Epub 2023 Apr 24. J Intensive Care Med. 2023. PMID: 37093762
-
[Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 May;31(5):539-544. doi: 10.3760/cma.j.issn.2095-4352.2019.05.004. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31198136 Chinese.
-
Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.BMC Gastroenterol. 2019 Nov 21;19(1):193. doi: 10.1186/s12876-019-1105-y. BMC Gastroenterol. 2019. PMID: 31752703 Free PMC article. Review.
-
Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.Pharmacotherapy. 2019 Mar;39(3):408-420. doi: 10.1002/phar.2172. Epub 2018 Sep 6. Pharmacotherapy. 2019. PMID: 30101529
Cited by
-
Using Body Composition Analysis for Improved Nutritional Intervention in Septic Patients: A Prospective Interventional Study.Nutrients. 2023 Aug 31;15(17):3814. doi: 10.3390/nu15173814. Nutrients. 2023. PMID: 37686846 Free PMC article. Clinical Trial.
-
Prediction model of death risk in patients with sepsis and screening of biomarkers for prognosis of patients with myocardial injury.Heliyon. 2024 Feb 29;10(5):e27209. doi: 10.1016/j.heliyon.2024.e27209. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38449610 Free PMC article.
References
-
- Krag M, Marker S, Perner A, Wetterslev J, Wise MP, Schefold JC et al. Pantoprazole in patients at risk for gastrointestinal bleeding in the ICU. N Engl J Med 2018; 379: 2199-208.
-
- Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S et al. Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 2015; 41: 833-45.
-
- Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5: 368-75.
-
- Krag M, Perner A, Wetterslev J, Wise MP, Borthwick M, Bendel S et al. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand 2015; 59: 576-85.
-
- Franchitti M, Piubellini J, Sadeghipour F, Eckert P, Voirol P, Schneider AG. Adequacy of stress ulcer prophylaxis prescription in the intensive care unit: an observational study. Swiss Med Wkly 2020; 150: w20322.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous